152 related articles for article (PubMed ID: 20230582)
1. Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma.
Starkey MP; Murphy S
Vet Comp Oncol; 2010 Mar; 8(1):56-71. PubMed ID: 20230582
[TBL] [Abstract][Full Text] [Related]
2. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression.
Wolfesberger B; Tonar Z; Witter K; Guija de Arespacohaga A; Skalicky M; Walter I; Thalhammer JG; Egger GF
Res Vet Sci; 2008 Aug; 85(1):56-61. PubMed ID: 17888471
[TBL] [Abstract][Full Text] [Related]
3. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
4. Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction.
Culmsee K; Gruber AD; von Samson-Himmelstjerna G; Nolte I
Res Vet Sci; 2004 Dec; 77(3):223-9. PubMed ID: 15276773
[TBL] [Abstract][Full Text] [Related]
5. Argyrophilic nucleolar organizing regions and Ki67 equally reflect proliferation in fine needle aspirates of normal, hyperplastic, inflamed, and neoplastic canine lymph nodes (n = 101).
Bauer NB; Zervos D; Moritz A
J Vet Intern Med; 2007; 21(5):928-35. PubMed ID: 17939545
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis.
Morrison C; Palatini J; Riggenbach J; Radmacher M; Porcu P
Cancer; 2006 Oct; 108(5):311-8. PubMed ID: 16944538
[TBL] [Abstract][Full Text] [Related]
8. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
9. Comparison of results of clinicians' assessments, cytologic examination of fine-needle lymph node aspirates, and flow cytometry for determination of remission status of lymphoma in dogs.
Williams LE; Broussard MT; Johnson JL; Neel J
J Am Vet Med Assoc; 2005 Feb; 226(4):562-6. PubMed ID: 15742697
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotype of canine lymph node aspirates.
Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
[TBL] [Abstract][Full Text] [Related]
11. Use of the argyrophilic nucleolar region method for cytologic and histologic examination of the lymph nodes in dogs.
Vajdovich P; Psáder R; Tóth ZA; Perge E
Vet Pathol; 2004 Jul; 41(4):338-45. PubMed ID: 15232133
[TBL] [Abstract][Full Text] [Related]
12. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
13. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
[TBL] [Abstract][Full Text] [Related]
14. Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology.
Corbi FC; Inaoka RJ; Felix RS; Andrade VC; Etto LY; Vettore AL; Franco MF; Colleoni GW
Diagn Mol Pathol; 2010 Mar; 19(1):40-4. PubMed ID: 20186011
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma.
Wilson CR; Regnier FE; Knapp DW; Raskin RE; Andrews DA; Hooser SB
Vet Comp Oncol; 2008 Sep; 6(3):171-81. PubMed ID: 19178677
[TBL] [Abstract][Full Text] [Related]
16. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.
Sözmen M; Tasca S; Carli E; De Lorenzi D; Furlanello T; Caldin M
J Vet Diagn Invest; 2005 Jul; 17(4):323-30. PubMed ID: 16130989
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
Lee JJ; Hughes CS; Fine RL; Page RL
Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
[TBL] [Abstract][Full Text] [Related]
18. Immunocytological detection of lymph node metastases in dogs with malignant epithelial tumours.
Höinghaus R; von Wasielewski R; Hewicker-Trautwein M; Freund M; Mischke R
J Comp Pathol; 2007 Jul; 137(1):1-8. PubMed ID: 17543325
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of canine lymphoma identifies potential cancer-specific protein markers.
McCaw DL; Chan AS; Stegner AL; Mooney B; Bryan JN; Turnquist SE; Henry CJ; Alexander H; Alexander S
Clin Cancer Res; 2007 Apr; 13(8):2496-503. PubMed ID: 17438110
[TBL] [Abstract][Full Text] [Related]
20. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
